Login / Signup
Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review.
Shen Chen
Yayi He
Juan Liu
Xiaoxia Chen
Jia Yu
Wei Li
Bin Chen
Chenglong Sun
Caicun Zhou
Published in:
OncoTargets and therapy (2019)
Regimens for the primary SCLC were also available for the transformed SCLC, but the duration of the response was short. NSE could be an effective biomarker for dynamic monitoring of the efficacy in SCLC transformation.
Keyphrases
</>
advanced non small cell lung cancer